Rhinomed (ASX:RNO) To Present At Master Investor UK Show

Sydney, Mar 31, 2015 - (ABN Newswire) - Rhinomed (ASX:RNO) is pleased to advise CEO Michael Johnson has been invited to provide the keynote address on the Rising Stars Stage at the 2015 Master Investor Show (www.masterinvestor.co.uk) to be held in London on 25th April, 2015.

Initiated by leading UK investor, Jim Mellon, Master Investor is regarded as the number one Investor Show in the UK and will be attended by approximately 3500 motivated investors, brokers and industry analysts.

Sir Steve Redgrave, CBE, heralded as one of the greatest Olympians of all time, having won 5 consecutive Olympic gold medals, will join Rhinomed on the podium. Sir Steve, who is a longstanding shareholder of Rhinomed and a brand ambassador, will be supporting the company and present alongside Rhinomed CEO Michael Johnson.

The Show coincides with National Stop Snoring Week in the UK, where Rhinomed and Sir Steve will be playing an active role in highlighting Rhinomed's recently released Mute technology that has been shown to reduce snoring and improve sleep quality.

Sleep is fast becoming recognised for its importance in recovery, quality of life and role in performance. "Rhinomed is delighted that Sir Steve can join the company at the Master Investor Show. Sir Steve brings a valuable perspective to the Rhinomed story and appreciates the importance breathing plays in delivering high-level performance and the role it plays in sleep, recovery and health." said CEO Michael Johnson.

Poor sleep is a well-recognised community heath problem, costing billions of dollars every year. It affects quality of life, work productivity, as well as behavior and relationship problems. The company's MuteĀ® technology not only reduces snoring but also radically improves sleep quality, by increasing the volume of air travelling through the nose during sleep, preventing congestion and encouraging nasal breathing.

The Master Investor Show is held at the Business Design Centre in London on Saturday 25th April 2015. Rhinomed will present on the Rising Stars Stage at 1.35pm, and will be at Exhibition booth #17 throughout the day. Rhinomed would like to invite shareholders to attend and a limited number of complimentary passes to the Show are available by contacting Rhinomed.

About: Rhinomed Ltd

Rhinomed Limited is a medical technology firm that focuses on nasal, respiratory and breathing management technologies. The company is monetising its technology portfolio in the Sport and recreation market, Sleep, Wellbeing and Drug delivery markets.

Rhinomed's technology is designed to radically improve the way you breathe sleep, maintain your health and take medication.

The first product brought to market is the Turbine(TM). A radical nasal technology that improves airflow by an average of 38%, the Turbine(TM) is an internal nasal dilator that has since it's launch in January 2014 in Australia, grown to be widely adopted by leading cyclists and triathletes globally.

Now shipped to over 36 countries and with a growing global distribution base, the Turbine(TM) is providing all those undertaking aerobic activities with an opportunity to breathe better, perform better and get more enjoyment from their sport and exercise.

Help employers find you! Check out all the jobs and post your resume.

Back to news